The human heart releases cardiotrophin-1 after coronary artery bypass grafting with cardiopulmonary bypass

Scand Cardiovasc J. 2011 Aug;45(4):252-6. doi: 10.3109/14017431.2011.585659. Epub 2011 Jun 15.

Abstract

Objectives: Cardiotrophin-1 (CT-1) is closely linked to many cardiovascular diseases, such as myocardial infarction and heart failure, and exhibits cardioprotective effect in ischemia-reperfusion injury. The present study was designed to investigate the course of CT-1 in patients undergoing on-pump coronary artery bypass grafting (CABG), and to evaluate the relationship between plasma CT-1 levels and postoperative cardiac function.

Methods: Twenty-four patients undergoing elective CABG were studied. Radial artery blood samples were collected before cardiopulmonary bypass (CPB), 5 min and 20 min after reperfusion, and 1 h, 6 h, 12 h and 24 h after CPB. Coronary sinus blood samples were collected before CPB, 5 min and 20 min after reperfusion. Plasma CT-1 levels were measured using the ELISA method. Hemodynamic data were collected.

Results: Peripheral CT-1 levels did not change significantly postoperatively. Trans-myocardial CT-1 levels increased significantly 5 min and 20 minutes after reperfusion as compared to baseline. A weak positive correlation (r = 0.408, p = 0.048) was found between trans-myocardial CT-1 levels at 20 min after reperfusion and CI at 12 h after CPB.

Conclusions: The heart secretes CT-1 after ischemic injury. The precise effect of CT-1 in CABG needs further investigation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cardiopulmonary Bypass*
  • Coronary Artery Bypass*
  • Cytokines / blood*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Hemodynamics / physiology
  • Humans
  • Male
  • Middle Aged
  • Perioperative Period

Substances

  • Cytokines
  • cardiotrophin 1